Bell ringing may ease distressing memories of cancer treatment
NCT ID NCT02970617
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether ringing a bell on the last day of radiation therapy helps cancer patients remember their treatment as less distressing. 82 patients took part. Researchers compared distress memory scores between those who rang a bell and those who did not.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- ringing a bell
- What this could lead to
- If it works, this simple ritual could help cancer patients feel less distressed when remembering their treatment.
- What could go wrong
- This is a small, completed study with no phase designation. The benefit may be minimal or not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
82 people
The number who actually took part.
- Started
-
Aug 2016
- Finished
-
Nov 2018
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosis of cancer * Definitive radiation treatment with or without concurrent chemotherapy with curative intent; treatment prior to radiation therapy is acceptable (e.g. surgery, chemotherapy) * Ability to understand and the willingness to sign a written informed consent; consents will be provided in English or Spanish * Able to speak English or Spanish (questionnaires will be in English and Spanish) Exclusion Criteria: * Patients with either a malignant central nervous system (CNS)-primary cancer or with brain metastases; patients do not need to undergo brain imaging unless indicated per standard workup and management (e.g. advanced stage lung cancer receiving definitive therapy) * Patients who will be receiving surgery or adjuvant chemotherapy within 1 month following radiation treatment * Patients with widespread metastatic disease (\> 3 distant metastases); patients with oligometastatic disease (=\< 3 distant metastases) are allowed only if they are receiving definitive (curative) radiation therapy (RT) with or without chemotherapy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Distress are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
USC / Norris Comprehensive Cancer Center
Los Angeles, California, 90033, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Pronged attack shrink advanced solid tumors?
- Can tumor avatars reveal why cancer hits minorities harder?
- AI therapy coach aims to ease distress in seriously ill seniors
- Blood test may one day personalize drug dosing after stem cell transplants
- New imaging agent aims to sharpen cancer detection
- Could a daily pill tame rare cancers in teens? new trial investigates